Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

US Patent 12351575 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alkyne derivative, preparation method for same, and uses thereof2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Macrolide derivatives, preparation method and application thereof2025
Pyrazolopyridine compounds for the treatment of autoimmune disease2025
Pyrazolopyridine compounds for the treatment of autoimmune disease2025
Pyrazolopyridine compounds for the treatment of autoimmune disease2025